Antidepressants Flashcards

1
Q

Depression is classified as

A
  • Major depression

* Bipolar depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

• Depressive episodes are characterized by:

A
  • Depressed or sad mood
  • Pessimistic worry
  • Diminished interest in normal activities
  • Feelings of worthlessness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

• Depressive symptoms also can be secondary to:

A
  • Hypothyroidism
  • Parkinson’s disease
  • Inflammatory conditions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

THE MONOAMINE HYPOTHESIS

A

“Depression may be due to lowered monoamine neurotransmitter at brain
synapses. Treatment of depression may be achieved by restoring the monoamine levels or actions to normality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

• The monoamine hypothesis was reinforced by the actions of antidepressants.

A

• Tricyclics block monoamine reuptake.
• MAO inhibitors block degradation of
monoamine neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WEAKNESSES OF THE

MONOAMINE HYPOTHESIS

A

• The pharmacological actions of both tricyclic and
MAO inhibitor classes of antidepressants are
immediate.
• But the clinical effects of the drugs take weeks.
• This discrepancy between biochemical and therapeutic effects suggests that the drugs trigger longer term changes.
• Depression may be linked to a deficiency in
signal transduction.
• Such a deficiency could lead to a deficient
response of target neurons to neurotransmission
and thus, depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ANTIDEPRESSANT DRUGS:

GENERAL FEATURES

A

• Antidepressants may take 2-4 weeks to produce
any improvement and 6-8 weeks to achieve
substantial benefit.
• All antidepressant drugs enhance monoamine
neurotransmission by one of several mechanisms.
• The most common mechanism is the inhibition
of the serotonin transporter (SERT), the norepinephrine transporter (NET), or both.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Types of antidepressant drugs?

A
Monoamine oxidase inhibitors
Tricyclic antidepressants
Serotonin selective reuptake inhibitors
Dual serotonin & norepinephrine reuptake inhibitors
5-HT2 antagonists/reuptake inhibitors
Norepinephrine & dopamine
reuptake inhibitors
Antagonists at alpha2, 5-HT2 & 5-HT3 receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List 4 MAOIs?

A
  • Isocarboxazid
  • Phenelzine
  • Tranylcypromine
  • Selegiline

• Monoamine oxidase inhibitors were the first
modern class of antidepressants.
• Introduced in the 1950s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MAOi moa?

A

• MAO is a mitochondrial enzyme that functions
as a “safety valve”.
• It inactivates excess norepinephrine, dopamine,
and serotonin that may leak out of synaptic
vesicles when the neuron is at rest.

• MAO inhibitors inactivate the enzyme:
neurotransmitter molecules escape degradation.
• This causes activation of norepinephrine and
serotonin receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

compare MAO-A and MAO-b?

A

• There are two isozymes of MAO: MAO-A and
MAO-B.
• MAO-A preferentially metabolizes norepinephrine
and serotonin.
• Both MAO-A and MAO-B metabolize dopamine
and tyramine.
• The antidepressant effect of MAOIs correlates
with inhibition of MAO-A.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MAOIs currently available for treatment of depression are:

A

• The hydrazine derivatives: phenelzine and isocarboxazid
• The non-hydrazines: tranylcypromine and
selegiline.

• Phenelzine, isocarboxazid, and tranylcypromine bind irreversibly and nonselectively to MAO-A and MAO-B.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selegiline moa?

A

• The MAO-B inhibitor selegiline is approved for
treatment of early Parkinson’s disease.
• Selegiline has antidepressant effects at high doses that also inhibit MAO-A.
• Selegiline is the first antidepressant available in
a transdermal delivery system

example: SELEGILINE PATCH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MAOIs: USES?

A

• MAO inhibitors are now rarely used in clinical
practice due to toxicity and food and drug
interactions.
• Used in treatment of depression unresponsive to other antidepressants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MAOi AE?

A
  • Drowsiness
  • Insomnia
  • Nausea
  • Orthostatic hypotension
  • Weight gain
  • Muscle pain
  • Sexual dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MAO inhibitors are associated with two classes

of serious drug interactions:

A
  • SEROTONIN SYNDROME

* CHEESE REACTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe SEROTONIN SYNDROME?

A

• The combination of a MAOI with a serotonergic
agent may result in serotonin syndrome.
• Life-threatening.
• The syndrome includes hyperthermia, muscle
rigidity and myoclonus.
• Serotonin syndrome is the result of overstimulation of 5-HT1A and 5-HT2 receptors.
• An irreversible MAOI with a serotonergic agent is the most toxic combination.
• But any drug or combination that increases
serotonin can cause serotonin syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SEROTONIN SYNDROME: MANAGEMENT?

A

• Discontinuation of all serotonergic agents.
• Supportive care.
• Sedation with benzodiazepines.
• Administration of the serotonin antagonist
cyproheptadine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the cheese reaction?

What other types of drugs and example can precipitate a cheese reaction?

A

• Tyramine is contained in certain foods, such as
aged cheeses, chicken liver, soy products, pickled
fish and red wines.
• Tyramine is normally inactivated by MAO in the gut.
• Patients on an MAOI cannot degrade tyramine.
• Tyramine then causes release of catecholamines
resulting in tachycardia, hypertension, arrhythmias,
seizures, and possibly, stroke.
• Sympathomimetic drugs may also cause significant hypertension when combined with an MAO inhibitor.
• OTC cold preparations that contain pseudoephedrine and phenylpropanolamine
are contraindicated in patients taking MAOIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

THE CHEESE REACTION: MANAGEMENT

A

• Phentolamine or prazosin are helpful in the
management of tyramine-induced hypertension.
• The selegiline transdermal patch is better
tolerated and safer.
• It is unlikely to cause tyramine-induced
hypertensive crisis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

List 5 TCAs?

A
  • Amitriptyline
  • Clomipramine
  • Desipramine
  • Imipramine
  • Nortriptyline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

moa of tca? Differences in moa between TCAs?

A

• TCAs block SERT and NET.
• This leads to increased monoamine concentration in the cleft.
• There is variability in affinity for SERT vs NET.
• For example, clomipramine is more selective for
SERT.
• Desipramine and nortriptyline are more selective for NET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TCA blocks which receptors?

A
  • TCAs block:
  • alpha-adrenergic receptors
  • Muscarinic receptors
  • Histamine receptors
  • Cardiac fast sodium channels
  • Blockade of these receptors are responsible for many adverse effects.
24
Q

TCA AE?

A

• Blockade of muscarinic receptors leads to
blurred vision, xerostomia, urinary retention, constipation and aggravation of narrow-angle glaucoma.
• Blockade of α1-adrenoceptors causes
orthostatic hypotension and reflex tachycardia.
• Blockade of H1 receptors causes sedation and weight gain.
• Blockade of cardiac fast sodium channels may
cause arrhythmias: most common cause of death
in patients with TCA intoxication.
• Sexual effects are common, particularly with highly serotonergic agents such as clomipramine.

25
Q

Discuss TCA overdose?

A

• The TCAs have a narrow therapeutic index.
• Overdose of TCAs can induce lethal arrhythmias.
• Sodium bicarbonate is useful in reversing
conduction block.

26
Q

List 6 SSRIs?

A
  • Citalopram
  • Escitalopram
  • Fluoxetine
  • Fluvoxamine
  • Paroxetine
  • Sertraline
27
Q

SSRIs: MECHANISM OF ACTION?

A

• SSRIs specifically inhibit serotonin reuptake.
• SSRIs have little blocking activity at muscarinic,
α-adrenergic, and histaminic H1 receptors.
• Adverse effects associated with TCAs, such as
orthostatic hypotension, sedation, dry mouth,
and blurred vision, are not seen with the SSRIs.

28
Q

SSRIs uses?

A

• SSRIs are the drugs of choice in treating
depression.

  • Depression
  • Obsessive compulsive disorder
  • Panic disorder
  • Generalized anxiety disorder
  • Post-traumatic stress disorder
  • Social anxiety disorder
  • Premenstrual dysphoric disorder
  • Bulimia
  • Premature ejaculation
29
Q

SSRIs: ADVERSE EFFECTS?

A

• Increased serotonergic activity in the gut is
associated with nausea, GI upset and diarrhea.
• Increased serotonergic tone at the level of the
spinal cord and above is associated with
diminished sexual function and interest.
• Some patients gain weight when taking SSRIs.

30
Q

SSRIs: DRUG INTERACTIONS

A

• Fluoxetine and paroxetine inhibit CYP2D6: high potential for drug interactions.
• Fluvoxamine inhibits CYP1A2, CYP2C19 and
CYP3A4: high potential for drug interactions.
• Citalopram, escitalopram and sertraline have
low potential for interactions.
• All SSRIs may cause a serotonin syndrome
when used in the presence of a MAO inhibitor or
another serotonergic drug.

31
Q

SSRIs: OVERDOSES?

A

• The likelihood of fatalities from SSRI overdoses
is extremely low.
• Overdoses may cause seizures.

32
Q
List 2 SEROTONIN & NOREPINEPHRINE
REUPTAKE INHIBITORS (SNRIs)
A
  • Venlafaxine

* Duloxetine

33
Q

SNRIs: MECHANISM OF ACTION? Drug interactions?

A

• Block reuptake of serotonin and norepinephrine.
• Differ from TCAs by their lack of blockade of H1,
muscarinic and α1 receptors.
• May be effective in treating depression in patients in whom SSRIs are ineffective.

SNRIs: DRUG INTERACTIONS
• SNRIs have relatively fewer CYP450 interactions than the SSRIs.

34
Q

Difference between venlafaxine and duloxetine?

A

Venlafaxine
• Potent inhibitor of 5HT uptake.
• At higher doses inhibits norepinephrine uptake.
• Also inhibits reuptake of dopamine very weakly

Duloxetine
• Inhibits serotonin and norepinephrine reuptake
at all doses.

35
Q
NOREPINEPHRINE & DOPAMINE
REUPTAKE INHIBITORS (NDRIs) example benefit and ae?
A

Bupropion
• Inhibits norepinephrine and dopamine uptake.
• Increases norepinephrine and dopamine release.
• Not associated to sexual dysfunction because it is not serotonergic.
• Bupropion is associated with seizures on overdose

36
Q

List 2 5HT2 ANTAGONISTS/REUPTAKE INHIBITORS

SARIs

A
  • Nefazodone

* Trazodone

37
Q

5HT2 ANTAGONISTS/REUPTAKE INHIBITORS (SARIs) action and ae

A

• When 5HT reuptake is blocked by SSRIs, all
5HT receptors are stimulated.
• Stimulation of 5HT1A receptors in raphe may
help depression.
• But stimulation of 5HT2 receptors may cause
anxiety and sexual dysfunction.
• SARIs combine 5HT reuptake blockade with
5HT2 antagonism
• This decreases undesired actions of stimulation
of 5HT2 receptors.
• Trazodone and Nefazodone are weak inhibitors of SERT and NET and potent antagonists at the
5-HT2 receptor.

38
Q

Compare 2 5HT2 antagonist/reuptake inhibitors?

A

NEFAZODONE
• Nefazodone has been associated with
hepatotoxicity.
• No longer commonly prescribed.

TRAZODONE
• Trazodone also blocks α1and H1 receptors.
• Extremely sedating.
• Excellent hypnotic.
• The main use of trazodone is as hypnotic.
• Rare but troublesome side-effect: priapism.

39
Q

NORADRENERGIC & SPECIFIC SEROTONERGIC

ANTIDEPRESSANTS (NASSA) example? Action and uses?

A

Mirtazapine
• Antagonist of central presynaptic alpha2
receptors: enhances release of norepinephrine and 5-HT.
• Antagonist at 5-HT2 and 5-HT3 receptors.
• H1 antagonist: sedation and weight gain.
• May be useful if insomnia or agitation is prominent.

40
Q

what is ANTIDEPRESSANT DISCONTINUATION

SYNDROME?

A

• Abrupt discontinuation of antidepressants is
associated with a discontinuation syndrome.
• Antidepressant discontinuation syndrome is most often seen in association with SSRI
discontinuation.
• This is because SSRIs are the most commonly
prescribed class of antidepressants.

41
Q

DISCONTINUATION SYNDROME: SYMPTOMS?

A
  • Anxiety. Irritability. Tearfulness
  • Dizziness
  • Headache
  • Lethargy
  • Flu-like symptoms
  • Electric-shock sensations
  • Insomnia
  • Nausea. Vomiting. Diarrhea.
42
Q

Incidence of discontinuation syndrome?

A

• Discontinuation syndrome is more likely with a
short half-life drug.
• The syndrome is most likely to occur with
paroxetine or venlafaxine due to their short
half-life.
• It is less likely to occur with fluoxetine due to its
long half-life.

43
Q

CHOICE OF DRUGS FOR DEPRESSION?

A

• An SSRI is usually the initial treatment of
choice for most patients with depression and
anxiety disorders.
• Their popularity comes from their ease of use,
tolerability and safety in overdose.

44
Q

ADJUNCTS FOR DEPRESSION?

A

ATYPICAL ANTIPSYCHOTICS
• Addition of an atypical antipsychotic may be
helpful when the response to antidepressant
agents is inadequate.

45
Q

CLINICAL INDICATIONS OF

ANTIDEPRESSANTS?

A

DEPRESSION
• SSRIs are the first choice.
ANXIETY DISORDERS
• SSRIs are the first choice.
• SSRIs can be used to treat GAD, SAD, PTSD,
PD and OCD.
• Bupropion is less effective than other antidepressants for treatment of anxiety.
EATING DISORDERS
• Antidepressants are helfpul for bulimia, but not
anorexia.
PREMENSTRUAL DYSPHORIC DISORDER
• SSRIs are beneficial to many women with
PMDD.
SMOKING CESSATION
• Bupropion is approved for smoking cessation.

46
Q

Antidepressant use in regard to chronic pain?

A

CHRONIC PAIN
• TCAs and SNRIs are used for neuropathic and
other pain conditions.
• Drugs that block NE and 5-HT reuptake are
often useful for pain disorders.
• SSRIs are not effective.

47
Q

ANTIDEPRESSANTS:

WARNINGS & PRECAUTIONS

A

• A major depressive episode may be the initial
presentation of bipolar disorder.
• Treating such an episode with an antidepressant
alone may precipitate mania in patients with
bipolar disorder.
• Before starting an antidepressant patients with depressive symptoms should be screened for
evidence of bipolar disorder.

48
Q

What is used for bipolar disorder?

A

LITHIUM
• Used prophylactically in treating manic depressive patients and in treatment of
manic episodes.
• Also effective in 60-80% patients with mania and hypomania
• The inositol depletion theory is the most widely
accepted explanation for the actions of lithium.

49
Q

Lithium moa?

A

• G protein-linked receptors coupled to Gq activate
PLC, which cleaves PIP2 to yield DAG and IP3.
• IP3 signaling is terminated by conversion to IP2.
• IP2 is converted to IP1 by inositol polyphosphatase.
• IP1 is converted to inositol by inositol monophosphatase.
• Lithium inhibits inositol polyphosphatase and
monophosphatase, thus blocking the regeneration of inositol.
• Free inositol is essential for the synthesis of PIP2.
• Therefore lithium blocks the phosphatidylinositol
signaling cascade in the brain.
• Inositol cannot cross the blood-brain barrier.
• Lithium inhibits inositol synthesis in CNS neurons.
• Lithium inhibits central adrenergic, muscarinic,
and serotonergic neurotransmission.
• Inhibition by lithium is uncompetitive.
• This means that only neurons with active receptors will be affected by lithium

50
Q

Lithium AE?

A

• Lithium has a narrow therapeutic window.

  • Tremor, sedation, ataxia, and aphasia.
  • Seizures.
  • Weight gain.
  • Hypothyroidism.
  • Nephrogenic diabetes insipidus.
  • Edema.
  • Dermatitis.
  • Alopecia.
  • Leukocytosis.
51
Q

Lithium ae remedies?

A

TREMOR
• Tremor can be alleviated with propranolol or atenolol.
NEPHROGENIC DIABETES INSIPIDUS
• When lithium-induced nephrogenic diabetes
insipidus is diagnosed, lithium should be
discontinued, if possible.
• If lithium cannot be discontinued amiloride
should be given.
• Other therapeutic options are: thiazides and
NSAIDs.

52
Q

Acute intoxication of lithium ae?

A
  • Acute intoxication is characterized by:
  • Vomiting
  • Profuse diarrhea
  • Coarse tremor
  • Ataxia
  • Coma
  • Convulsions
53
Q

Lithium in pregnancy?

A
• The use of lithium during pregnancy may
increase incidence of congenital cardiac
anomalies.
• Category D.
• Contraindicated in nursing mothers.
54
Q

LITHIUM: MONITORING

A
  • The following must be regularly monitored:
  • Serum lithium concentrations
  • Thyroid function
  • Renal function
55
Q

LITHIUM: DRUG INTERACTIONS

A
  • Renal clearance of lithium is reduced by:
  • Thiazide diuretics
  • NSAIDs
  • ACE inhibitors
  • ARBs
56
Q

ALTERNATIVES TO LITHIUM?

A
Other alternatives:
• Atypical antipsychotics:
• Olanzapine
• Aripiprazole
• Quetiapine
• Risperidone
• Ziprasidone
  • Antiepileptics:
  • Lamotrigine
57
Q

ALTERNATIVES TO LITHIUM widely used

A

• The antiepileptics valproate and carbamazepine are widely used.
• Liver function and CBC should be monitored in
patients taking valproic acid.
• CBC should be monitored in patients taking
carbamazepine.